Scientific Advisory Board
Dr. Felder, is Chairman of the Premier Biomedical Scientific Advisory Board. He is a Board Certified Neurologist and former CEO, President, Chairman and founder of Infectech and Nanologix. Dr. Felder acquired a B.A. Degree from the University of Pennsylvania in 1975 and a M.D. Degree from the University of Rome, Faculty of Medicine in 1983. Dr. Felder did his residency at Saint Vincent Hospital in New York, New York, where he was chosen to be Chief Resident in Neurology. He has been Board Certified by both the American Academy of Clinical Neurology and the American Board of Psychiatry and Neurology. Dr. Felder is a Clinical Assistant Professor in the Department of Neurology at the Texas Tech University Health Sciences Center. Dr. Felder has authored or co-authored six publications, three studies and has currently 18 issued patents. Dr. Felder was the Acting Chief of the Department of Neurology, Sharon Regional Health System from 1989 until 2001. Dr. Felder served as the Acting Chief of the Department of Neurology at the William Beaumont Army Medical Center in 2011.
Mr. Dubov is a subject matter expert in regulations and guidance for all articles regulated by the Food & Drug Administration (FDA). He has extensive experience with all phases of clinical trials and marketing approval. He has been involved with both U.S. military and civilian applications related to the review and submissions for approval of clinical trials for drugs (Investigational New Drugs, Abbreviated New Drug Applications), devices (Non-Significant Risk, 510(k), Investigational Device Exemption, Premarket Approval), biologics (Biological Investigational New Drugs, and biosimilars), combination products, and other articles regulated by the FDA.
Mr. Dubov was awarded Regulatory Affairs Certification (RAC) in December, 2011, and recertified in June, 2014. He is a Certified Institutional Review Board Professional (CIP) and a member of the Regulatory Affairs Professional Society (RAPS), and of Public Responsibility in Medicine and Research (PRIM&R).
Mr. Dubov received his Juris Doctorate from University of the Pacific, McGeorge School of Law in Sacramento, California. He holds Master of Business Administration (International Finance) from Trident University International, Culver City, California.
Dr. Reyes is board certified and a neuropathologist who is Chief Medical Officer and Board Member of the Retired National Football League Players Association. He is a board member, and former Chair of the Education Committee and 2009 Distinguished Educator of the Association of Ringside Physicians. He is a Fellow of the American Academy of Neurology and was former Professor of Neurology and Neuropathology at Thomas Jefferson Medical School in Philadelphia, Pennsylvania and Professor of Neurology, Pathology and Psychiatry at Creighton University School of Medicine in Omaha, Nebraska.
Dr. Reyes is a co-founder, Chief Medical Officer and Chair of the Scientific Advisory Board of Yuma Therapeutics, Inc., a Harvard Medical School affiliated Biotechnology Company that develops new diagnostic markers and treatment for Alzheimer’s disease and traumatic brain injury. Dr. Reyes is a pioneer in the fields of Aging, Alzheimer’s disease and other neurodegenerative diseases. He established the first Dementia and Alzheimer’s disease clinic and Rapid Brain Autopsy System in the country while he was in Texas and subsequently in Pennsylvania and Nebraska. He was one of the principal investigators who worked on multiple clinical trials that led to the first US FDA approved drug for Alzheimer’s disease and the only skin patch treatment for the same disorder. He and his co-workers were one of the first to describe the olfactory deficits and their anatomical and neuropathological changes in Alzheimer’s disease.
Dr. Reyes obtained his medical degree from the University of the Philippines and started his residency in Internal Medicine and Neurology at the Philippine General Hospital. He pursued his training in Adult and Child Neurology at the University of Kentucky Medical Center, and Neuropathology at the University Of Miami School Of Medicine. His first academic position was to head the Neurology Division of Audie Murphy VA Hospital and as an assistant professor of Neurology and Pathology at the University of Texas Health Science Center in San Antonio.
Dr. Fields is an Assistant Professor of Surgical Oncology at Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine in St. Louis, Missouri. He also serves as an Associate Program Director for the General Surgery Residency Program and is Director of Resident Research. Dr. Fields completed his undergraduate studies at the University of Michigan where he was mentored in Cancer Immunology and Biology. He received his MD degree from Duke University and completed a General Surgery Residency at Barnes-Jewish Hospital at Washington University School of Medicine in St. Louis.
After completing a Surgical Oncology Fellowship at Memorial Sloan-Kettering Cancer Center, Dr. Fields joined the faculty at Washington University. His clinical interests include the treatment of primary and secondary/metastatic liver tumors, pancreatic cancer, gastric cancer, sarcoma, and melanoma/skin cancer. His research focuses on the biology and genetics of cancer metastases. Through collaborations with The McDonnell Genome Institute at Washington University and colleagues in the Department of Medical Oncology, Dr. Fields and his team are applying cutting edge genomic techniques to investigate the changes a tumor undergoes from primary malignancy to metastatic disease.
Dr. Carl Meyer is a pediatrician and a Fellow of the American Academy of Pediatrics. He has been a practicing pediatrician for 35 years, initially in solo practice in Greenville, PA, and currently with Hope Pediatrics in Seneca, PA. He received his undergraduate degree from Florida Atlantic University in Boca Raton, and his Doctor of Osteopathic Medicine from the Philadelphia College of Osteopathic Medicine.
Dr. Carl Meyer spent many years on staff at University of Pennsylvania Medical Center (UPMC) Horizon as a general pediatrician, Chair of the Department of Pediatrics, and President of the Medical Staff. He also served as Medical Director of Quality and Risk Management for three years, earning his MBA from Alvernia College in Reading, PA to enhance his work in Medical Quality. As a pediatrician, Dr. Carl Meyer has participated in over 75 clinical research studies in childhood immunizations, and has authored a book on child care and contributed material for books and newspapers. He has been a clinical instructor for several medical schools and physician assistant programs for many years.
Kathryn Meyer is an Emergency Physician, certified by the American Academy of Osteopathic Emergency Physicians. She received her undergraduate degree from Penn State University and her Doctor of Osteopathic Medicine from the Philadelphia College of Osteopathic Medicine. She is currently Medical Director of the University of Pennsylvania Medical Center (UPMC) Hermitage Urgent Care Center in Hermitage, PA. Prior to that, she practiced Emergency Medicine at UPMC Horizon for 30 years.
During her career, Dr. Kathryn Meyer has been the Medical Director of local ambulance companies. She served as Assistant Medical Director of Emergency Medicine for UPMC Horizon for 15 years and was appointed to Medical Staff committees for Medical Care and Risk Management. She has been an instructor for Advance Cardiac Life Support program for many years.